State ME
Clinical Trials in Maine
Maine is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Maine and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
Right now ClinicalMetric tracks 39 actively recruiting studies with Maine sites out of 39 registered in total. The busiest research areas in Maine are Acute Myeloid Leukemia, Breast Neoplasms, Endometrial Cancer. Leading sponsors running trials in the state include National Cancer Institute (NCI), Merck Sharp & Dohme LLC, Children's Oncology Group. By stage, Maine trials break down as Phase 1 (2), Phase 2 (8), Phase 3 (17), Phase 4 (2).
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in Maine
Acute Myeloid Leukemia (2)Breast Neoplasms (2)Endometrial Cancer (2)Lung Non-Small Cell Carcinoma (2)Breast Cancer (2)Neovascular Age-related Macular Degeneration (1)Renal Cell Carcinoma (1)Non-Traumatic Subarachnoid Hemorrhage (1)Ganglioneuroblastoma, Nodular (1)Neuroblastoma (1)Advanced Endometrial Carcinoma (1)Recurrent Endometrial Carcinoma (1)
Frequently Asked Questions — Clinical Trials in Maine
How many clinical trials are currently recruiting in Maine?
ClinicalMetric currently tracks 39 actively recruiting clinical trials with at least one location in Maine. The total number of registered studies—including active but not currently enrolling trials—is 39. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Maine?
Maine hosts clinical trials across a broad range of medical conditions, including Acute Myeloid Leukemia, Breast Neoplasms, Endometrial Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Maine serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Maine?
To join a clinical trial in Maine, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Maine maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Maine
NCT07561593 N/A
Recruiting
Improving Health Outcomes Through Investigations of Wabanaki Food Systems in Mai...
Condition
Food Insecurity
Enrollment
500 pts
Location
United States
Sponsor
Wabanaki Public Health and Wel
NCT07228026 N/A
Recruiting
Use of fenoTRACK Device for Monitoring Changes of Fractional Exhaled Nitric Oxid...
Condition
Asthma
Enrollment
160 pts
Location
United States
Sponsor
Biometry Inc
NCT04609046 Phase 1
Recruiting
Testing the Addition of Lenalidomide and Nivolumab to the Usual Treatment for Pr...
Condition
Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System
Enrollment
47 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT00358943 N/A
Recruiting
International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Preg...
Condition
Gaucher Disease
Enrollment
12,000 pts
Location
United States, Argentina, Australia
Sponsor
Genzyme, a Sanofi Company
NCT05918861 Phase 3
Recruiting
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Rece...
Condition
Acute Coronary Syndrome
Enrollment
2,000 pts
Location
United States, Canada, Puerto Rico
Sponsor
DalCor Pharmaceuticals
NCT04402788 Phase 2, Phase 3
Recruiting
Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment ...
Condition
Extensive Stage Lung Small Cell Carcinoma
Enrollment
138 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT04322318 Phase 2
Recruiting
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and R...
Condition
Anaplastic Kidney Wilms Tumor
Enrollment
256 pts
Location
United States, Australia, Canada
Sponsor
Children's Oncology Group
NCT00231400 N/A
Recruiting
Pompe Disease Registry Protocol
Condition
Glycogen Storage Disease Type II
Enrollment
2,000 pts
Location
United States, Argentina, Australia
Sponsor
Genzyme, a Sanofi Company
NCT04267848 Phase 3
Recruiting
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemoth...
Condition
Lung Non-Small Cell Carcinoma
Enrollment
1,210 pts
Location
United States, Guam
Sponsor
National Cancer Institute (NCI
NCT03053193 N/A
Recruiting
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluat...
Condition
Breast Cancer
Enrollment
30,000 pts
Location
United States, Canada, Greece
Sponsor
Agendia
NCT07214532 N/A
Recruiting
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Condition
Breast Neoplasms
Enrollment
725 pts
Location
United States
Sponsor
Natera, Inc.
NCT07243652 N/A
Recruiting
I-DECIDE After Bronchiolitis Hospitalization
Condition
Bronchiolitis Acute
Enrollment
2,700 pts
Location
United States
Sponsor
Seattle Children's Hospital
NCT06876714 Phase 3
Recruiting
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People W...
Condition
Anatomic Stage I Breast Cancer AJCC v8
Enrollment
1,524 pts
Location
United States, Puerto Rico
Sponsor
Alliance for Clinical Trials i
NCT03851445 Phase 2, Phase 3
Recruiting
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung...
Condition
Previously Treated Non-Small Cell Lung Cancer
Enrollment
10,000 pts
Location
United States
Sponsor
SWOG Cancer Research Network
Page 2 of 2 — 39 trials total
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology